- 93% of Part D lives have unrestricted access to LINZESS
8 out of 10 commercially insured patients pay no more than $30 for LINZESS.28*
*This includes patients who participate in the LINZESS Savings Program.
Formulary status information is valid as of April 2019. Coverage is subject to change. Some plan clients may make independent coverage decisions. Kaiser Permanente is not included in access numbers.
Source: MMIT data as of January 2018. Data are subject to change. Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurers. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.